Company: SCLXW
Filing Date: 2025-02-26
Form Type: PRER14A
Source: 0001193125-25-036730
Chunk: 39

Company: Scilex Holding Co
Filing Date: 2025-02-26
Form: PRER14A
Chunk 39
---
31, 2025, 139,333                                 
 shares held directly and an aggregate of 155,882 shares held by family trusts for the benefit of Mr. Shah, his spouse and his children. |

| (3) | Represents 6,977,541 shares subject to options exercisable within 60 days of January 31, 2025, 320,161                                                                                                                              
 shares held directly, an aggregate of 62,819 shares held through an entity owned by Dr. Ji, 5,640 shares held by Dr. Ji’s spouse and an aggregate of 292,264 shares held by family trusts for the benefit of Dr. Ji, his spouse and 
 his children.                                                                                                                                                                                                                       |

| (4) | Represents 360,569 shares subject to options exercisable within 60 days of January 31, 2025 and 22,840 
 shares held directly.                                                                                  |

| (5) | Represents 101,041 shares subject to options exercisable within 60 days of January 31, 2025, 112,500 
 shares held directly and 11 shares held by Dr. Chun’s child.                                         |

| (6) | Represents 195,192 shares subject to options exercisable within 60 days of January 31, 2025 and 2,300 
 shares held directly.                                                                                 |

| (7) | Represents 36,457 shares subject to options exercisable within 60 days of January 31, 2025. |

| (8) | Represents 505,139 shares subject to options exercisable within 60 days of January 31, 2025 and 25,000 
 shares held directly.                                                                                  |

| (9) | Represents (a) 51,039,214 shares of Common Stock held directly and (b) 490,617 shares underlying SPAC                                                                                                                                                                                                                                   
 Warrants (as defined in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the SEC on March 12, 2024 (the “Form 10-K”)), all of which are currently exercisable, in each case, transferred to SCLX JV in connection with the Equity Repurchase Transaction (as defined in the Form 10-K). 
 Does not include any shares of Series A Preferred Stock. The voting and dispositive power of the equity securities of the Company (including the Series A Preferred Stock) held by SCLX JV are subject